Using Phenazopyridine for In-office Cystoscopy
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 94
- 试验地点
- 1
- 主要终点
- Total cystoscopy time
研究概览
简要总结
The investigators propose to conduct a randomized controlled trial to evaluate whether administration of phenazopyridine prior to the procedure decreases office cystoscopy time. Women undergoing in-office cystoscopy at Boston Urogynecology will be recruited.
详细描述
All potentially eligible participants will have had a complete history, physical examination, urinalysis and urine culture for clinical purposes. After eligibility is confirmed and written, informed consent is obtained, participants will be randomized to one of the two study arms. Participants randomized to phenazopyridine arm will receive 200 mg by mouth approximately 60 minutes prior to the scheduled cystoscopy. During the cystoscopy, at various time points, the time will be recorded.The color of the efflux will also be documented.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Female patients undergoing in-office diagnostic cystoscopy at Boston Urogynecology Associates
排除标准
- •Women who have taken vitamin B the day of the cystoscopy
- •Cystoscopy with concurrent treatments such as botulinum toxin or periurethral bulking injections
- •Allergy to phenazopyridine
研究组 & 干预措施
Phenazopyridine before cystoscopy
This group will receive 200mg of phenazopyridine prior to cystoscopy
干预措施: Phenazopyridine (Drug)
结局指标
主要结局
Total cystoscopy time
时间窗: at time of cystoscopy
The total time of cystoscopy will be measured
次要结局
- Time to visualization of ureteral jets(at time of cystoscopy)
研究者
Eman Elkadry, M.D.
Principle Investigator
Boston Urogynecology Associates